Lifeway Foods(US:LWAY) Prnewswire·2025-11-12 14:00Core Insights - Lifeway Foods achieved record net sales of $57.1 million in Q3 2025, marking a 29% increase in volume-led net sales on a comparable basis, driven primarily by its flagship product, Lifeway Kefir [1][2] - The company has experienced six consecutive years of quarterly net sales growth, with a significant gross margin expansion of 300 basis points and a net income growth of 19% [1][2] - Lifeway is focusing on health and wellness trends, including the rise in GLP-1 medication use and gut health awareness, and is investing in marketing and manufacturing capabilities to support future growth [2] Financial Performance - Net sales reached $57.1 million, up 24% year-over-year and approximately 29% on a comparable basis [7] - Gross profit margin increased to 28.7%, up from 25.7% the previous year [7] - Net income for the quarter was $3.5 million, or $0.23 per share, compared to $3.0 million, or $0.20 per share, in the prior year [7][16] Strategic Initiatives - Lifeway is expanding its product offerings with new innovations such as Muscle Mates™, a ready-to-drink functional beverage with 20 grams of protein, and Probiotic Smoothies with Collagen [3][4] - The company has partnered with health-focused brands to enhance the visibility of Kefir in high-profile products, including a limited-edition smoothie with Erewhon and a functional drink with Joe & The Juice [5][7] - The first stage of the strategic expansion of the Waukesha plant has been completed, increasing capacity and operational efficiency [2][8] Market Outlook - Lifeway reiterated its long-term target of $45–$50 million in Adjusted EBITDA for FY 2027 and is on track for the strongest annual sales in company history for FY 2025 [8] - The company is confident in its ability to sustain growth momentum, with record quarters and expanding margins [8]